Attached files
| file | filename |
|---|---|
| EX-99.3 - TODOS MEDICAL LTD. | ex99-3.htm |
| EX-99.2 - TODOS MEDICAL LTD. | ex99-2.htm |
| EX-99.1 - TODOS MEDICAL LTD. | ex99-1.htm |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): June 28, 2021
Todos Medical Ltd.
(Exact name of registrant as specified in its charter)
| Israel | 000-56026 | n/a |
| (State or other jurisdiction | (Commission | IRS Employer |
| of incorporation or organization) | File Number) | Identification No.) |
121 Derech Menachem Begin, 30th Floor
Tel Aviv, 6701203 Israel
(Address of principal executive offices)
Registrant’s telephone number, including area code: 972 (52) 642-0126
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| [ ] | Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| [ ] | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| [ ] | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| [ ] | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act: None
Indicate by check mark whether the registrant is an emerging growth company as defined in as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company [X]
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. [ ]
Item 8.01 Other Items
On June 28, 2021, Todos Medical Ltd. (the “Company”) filed its Notice and Proxy Statement for the Annual General Meeting of Shareholders of the Company to be held on July 26, 2021. The Notice and Proxy Statement is attached hereto as Exhibit 99.1 and the Proxy Card for the Annual General Meeting of Shareholders of the Company is attached hereto as Exhibit 99.2.
Item 9.01. Financial Statements and Exhibits
(d) Exhibits.
| -2- |
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Dated: June 28, 2021
| TODOS MEDICAL LTD. | ||
| By: | /s/ Gerald Commissiong | |
| Gerald Commissiong | ||
| Chief Executive Officer | ||
| -3- |